To the Editor We read the article by Yousef et al titled “Intra-arterial Chemotherapy for Retinoblastoma: A Systematic Review.”1 From our perspective from an intra-arterial chemotherapy (ophthalmic artery chemosurgery [OAC]) program in Argentina, we believe that some issues limit the validity of their conclusions regarding the risk of metastatic relapse.
Chantada G, Schaiquevich P. Intra-arterial Chemotherapy for Retinoblastoma. JAMA Ophthalmol. 2016;134(10):1202–1203. doi:10.1001/jamaophthalmol.2016.2724
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: